Entanglement Technologies has become a member of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) to further explore AROMA-technology-led solutions for process monitoring in biomanufacturing. NIIMBL is a public-private consortium composed of more than 200 members and federal stakeholder agencies across a diverse set of groups, including large and small companies, research institutions, community colleges, non-profit organizations, and government. Their mission is to “accelerate biopharmaceutical innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical manufacturing workforce, fundamentally advancing U.S. competitiveness in the industry.”
Entanglement Technologies will be presenting a poster at the NIIMBL 2023 National Meeting June 27 – 29th in Washington D.C. The work is in collaboration with the North Carolina Biotechnology Training and Education Center (NC BTEC) to monitor methanol and other volatile organic compounds (VOCs) in bioreactor headspace during a Pichia pastoris fermentation process.